FDA approves Alzheimer's drug lecanemab from Eisai, Biogen
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.
Source: timestelegram.com
Page 4 - Toronto Memory Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Toronto Memory Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Toronto Memory Program Today - Breaking & Trending Today
FDA approves Alzheimer's drug lecanemab from Eisai, Biogen
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.
Source: usatoday.com
Report shares new details about death possibly linked to experimental Alzheimer's drug
The death of a participant in a clinical trial of an antibody treatment for Alzheimer's disease, which is now under consideration by the FDA, may be linked to the experimental drug, a new report shows.
Source: ksl.com
NewCa.com: ⚕️ New Ontario Dementia Care Alliance Launches to
- Expert panel to provide proactive, evidence-informed recommendations that are costed and implementable - A panel of 17 leading experts in dementia care
Source: newca.com
Is lecanemab the Alzheimer's drug that will finally make a difference?
A drug that offers a small benefit to Alzheimer's patients is making a big splash with doctors who treat the disease.The drug, a monoclonal antibody called lecanemab, dominated last week's Cli
Source: woub.org